Page 1 of Clinical Trials for Drug TMC278, 26 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Recruiting
Study in Healthy Volunteers of the Safety and Metabolism of Different Doses of the Anti-HIV Drug TMC278LA.
Last Updated: January 27, 2011
Condition(s): HIV Infection
2
Completed
TMC278-TiDP6-C121: Drug-drug Interaction Trial to Investigate the Potential Interaction Between TMC278 25 mg Daily and Methadone, at Steady State.
Last Updated: April 26, 2010
Condition(s): HIV
3
Completed
TMC435-TiDP16-C114 - A Study in Healthy Volunteers Investigating the Pharmacokinetic Interaction Between TMC435 and the Antiretroviral Agents TMC278 and Tenofovir
Last Updated: November 23, 2011
Condition(s): Hepatitis C Virus
4
Completed
TMC278-TiDP6-C136: Effect of TMC278 on Ethinylestradiol and Norethindrone in Healthy Women.
Last Updated: April 26, 2010
Condition(s): HIV; AIDS; Oral Contraceptive
5
Recruiting
Drug Interaction Study Between Digoxin and TMC278
Last Updated: February 9, 2012
Condition(s): HIV-1
6
Completed
TMC125IFD1001 - Drug-Drug Interaction of Etravirine With Telaprevir and TMC278 With Telaprevir.
Last Updated: December 30, 2011
Condition(s): Hepatitis C; HIV
7
Active, not recruiting
TMC278-C204: TMC278 in Treatment Naive HIV-1 Infected Subjects
Last Updated: July 7, 2011
Condition(s): HIV Infection
8
Not yet recruiting
A Study to Evaluate the Pharmacokinetics and Safety of GSK1265744 and Rilpivirine and Dolutegravir and Rilpivirine in Healthy Adult Subjects
Last Updated: November 3, 2011
Condition(s): Human Immunodeficiency Virus
9
Completed
TMC278-TiDP6-C153 - A Study in Healthy Volunteers Investigating the Pharmacokinetic Interaction Between TMC278 and Raltegravir
Last Updated: June 23, 2011
Condition(s): HIV Infections
10
Terminated
Pre-Exposure Prophylaxis Using TMC278LA
Last Updated: August 13, 2010
Condition(s): HIV Infections
11
Active, not recruiting
TMC278-TiDP6-C209: A Clinical Trial in Treatment Naive HIV-1 Patients Comparing TMC278 to Efavirenz in Combination With Tenofovir + Emtricitabine.
Last Updated: December 7, 2011
Condition(s): HIV Infections; HIV-1; Human Immunodeficiency Virus Type 1
12
Active, not recruiting
TMC278-TiDP6-C215: A Clinical Trial in Treatment Naive HIV-subjects Patients Comparing TMC278 to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors
Last Updated: December 6, 2011
Condition(s): HIV Infections; HIV-1
13
Completed
TMC278-TiDP6-C130: Pharmacokinetics, Safety and Tolerability of TMC278 in Subjects With Mildly or Moderately Impaired Hepatic Function.
Last Updated: April 26, 2010
Condition(s): HIV; AIDS; Hepatic Impairment
14
Completed
TMC278-TiDP15-C158 - A Study to Examine the Safety, Tolerability and Pharmacokinetics of a Single Dose or Three Successive Doses of Intramuscularly (IM) Injected Long Acting Formulation of TMC278
Last Updated: December 12, 2011
Condition(s): HIV Infections
15
Completed
TMC278-TiDP6-C154: Evaluation of the Possible Influence of Omeprazole Intake - and the pH Increase in the Stomach Triggered by Omeprazole Intake - on the Blood Levels of TMC278 in Healthy Volunteers
Last Updated: July 8, 2010
Condition(s): HIV Infections
16
Completed
TMC278-TiDP6-C152: A Study to Assess the Effects of TMC278 and Efavirenz (EFV) on the QT/QTc Interval (Heart Conduction and Heart Rhythm) in Healthy Volunteers.
Last Updated: June 8, 2011
Condition(s): Human Volunteers
17
Completed
TMC278-TiDP38-C145: A Bioavailability Study in Healthy Adult Volunteers to Evaluate 3 Pediatric Formulations of TMC278 (a Solution, a Suspension, and Granules) Compared to an Adult Tablet Formulation
Last Updated: June 8, 2011
Condition(s): Pharmacokinetics; Bioavailability; HIV-1
18
Recruiting
TMC278-TiDP38-C213 (PAINT): An Open Label Trial to Evaluate the Pharmacokinetics, Safety, Tolerability and Antiviral Efficacy of TMC278 in Antiretroviral Naive HIV-1 Infected Adolescents
Last Updated: January 24, 2012
Condition(s): HIV Infections; HIV-1
19
Active, not recruiting
Study to Evaluate the Safety and Efficacy of a Single Tablet Regimen of Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate Compared With a Single Tablet Regimen of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Adults.
Last Updated: August 9, 2011
Condition(s): HIV-1 Infection
20
Active, not recruiting
Study to Evaluate Switching From Regimens Consisting of Ritonavir-boosted Protease Inhibitor (PI) and Two Nucleoside Reverse Transcriptase Inhibitors (NRTIs) to a Fixed Dose Tablet Containing Emtricitabine/Rilpivirine/Tenofovir DF
Last Updated: June 24, 2011
Condition(s): HIV-1 Infection

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://www.clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+TMC278

Page 1 of Clinical Trials for Drug TMC278, 26 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About